Validation of the revised International Prognostic Scoring System in patients with myelodysplastic syndrome in Japan: results from a prospective multicenter registry-Reference-Cited by-同舟云学术

Validation of the revised International Prognostic Scoring System in patients with myelodysplastic syndrome in Japan: results from a prospective multicenter registry

Published:2017-05-11 Issue:3 Volume:106 Page:375-384
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Kawabata Hiroshi^ORCID, ,Tohyama Kaoru,Matsuda Akira,Araseki Kayano,Hata Tomoko,Suzuki Takahiro,Kayano Hidekazu,Shimbo Kei,Zaike Yuji,Usuki Kensuke,Chiba Shigeru,Ishikawa Takayuki,Arima Nobuyoshi,Nogawa Masaharu,Ohta Akiko,Miyazaki Yasushi,Mitani Kinuko,Ozawa Keiya,Arai Shunya,Kurokawa Mineo,Takaori-Kondo Akifumi

Funder

Ministry of Health, Labor and Welfare, Japan

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/article/10.1007/s12185-017-2250-0/fulltext.html

Reference21 articles.

1. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89:2079–88.

2. Balduini CL, Guarnone R, Pecci A, Centenara E, Ascari E. International prognostic scoring system and other prognostic systems for myelodysplastic syndromes. Blood. 1997;90:4232–4.

3. Malcovati L, Germing U, Kuendgen A, Della Porta MG, Pascutto C, Invernizzi R, et al. Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. J Clin Oncol. 2007;25:3503–10.